← Back to Vaccine Database

Recombinant SARS-CoV-2 vaccine (CHO Cell)

Protein based vaccine · VDDBV0644

Target & Classification

SARS-CoV-2SARS-CoV-2
Protein based vaccine
COVID-19
Phase 3

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials17

NCT IDPhaseDisease / Condition
NCT04445194 Phase 1COVID-19
NCT04636333 Phase 1COVID-19
NCT04961359 Phase 1COVID-19
NCT04550351 Phase 2COVID-19
NCT05205083 Phase 2COVID-19
NCT05198063 Phase 2COVID-19
NCT05198102 Phase 2COVID-19
NCT04813562 Phase 2COVID-19
NCT05205096 Phase 2COVID-19
NCT04466085 Phase 2COVID-19
NCT05109598 Phase 2COVID-19
NCT05091411 Phase 3COVID-19
NCT04646590 Phase 3COVID-19
NCT05128643 Phase 3COVID-19
NCT04869592 Phase 2COVID-19
NCT05069129 Phase 2COVID-19
NCT05293548 Phase 2COVID-19